Natco Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.
Natco Pharma Ltd., with Security Code 524816, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 10,683.00 | 3,863.00 | 11,103.00 | 21.56 | -2,859.00 | 420.00 | -555.00 | 4,776.00 |
2023-10-01 | 2023-12-31 | 6,253.00 | 1,920.00 | 6,548.00 | 10.72 | -1,724.00 | 295.00 | -404.00 | 2,236.00 |
2023-10-01 | 2023-12-31 | 7,586.00 | 2,127.00 | 7,956.00 | 11.88 | -2,064.00 | 370.00 | -442.00 | 2,563.00 |
2023-07-01 | 2023-09-30 | 9,305.00 | 3,602.00 | 9,552.00 | 20.11 | -2,005.00 | 247.00 | -400.00 | 4,240.00 |
Compounded Sales Growth | |
---|---|
10 Years: | 19% |
5 Years: | 12% |
3 Years: | 29% |
TTM: | 52% |
Compounded Profit Growth | |
---|---|
10 Years: | 28% |
5 Years: | 15% |
3 Years: | 66% |
TTM: | 110% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 17% |
3 Years: | 1% |
1 Year: | 73% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 14% |
3 Years: | 25% |
TTM: | 48% |
Compounded Profit Growth | |
---|---|
10 Years: | 30% |
5 Years: | 17% |
3 Years: | 49% |
TTM: | 98% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 17% |
3 Years: | 1% |
1 Year: | 73% |